National Children’s Study launches in St. Louis this week
The National Children’s Study, the largest study ever conducted in the United States to learn about the health and development of children, is beginning in St. Louis this week.
Alzheimer’s patients can’t effectively clear sticky plaque component
Neurologists finally have an answer to one of the most important questions about Alzheimer’s disease: Do rising brain levels of a plaque-forming substance mean patients are making more of it or that they can no longer clear it from their brains as effectively? A new study by Randall Bateman, MD, assistant professor of neurology, shows clearance is impaired in Alzheimer’s patients.
Sharing holiday spirit
School of Medicine students showcase their artistic talents at the Dec. 2 coffeehouse at the Farrell Learning and Teaching Center. Medical students such as Kristen Danley gather a few times a year to sing, play piano and other instruments and read poetry.
Spine center opens in Chesterfield
Washington University Orthopedics has opened a spine center at its outpatient facility in Chesterfield, Mo., to provide comprehensive, specialized care to patients with spine injuries and disorders.
Deliverance in the details
Alan Pestronk’s experience with neurodegenerative disease helps him tune in to the patient and the caregivers.
The gene-environment enigma
A new study shows that the environment interacts with DNA in ways that are difficult to predict, even in simple organisms like single-celled yeast, which complicates the prospects for personalized medicine.
Renowned child-health researcher named Fred M. Saigh Distinguished Chair in Pediatric Research
Mary C. Dinauer, MD, PhD, has been named the first Fred M. Saigh Distinguished Chair in Pediatric Research at Washington University School of Medicine in St. Louis and St. Louis Children’s Hospital.
Washington University opens clinic for treatment-resistant depression
Washington University School of Medicine has opened a clinic for patients with treatment-resistant depression that targets those who haven’t responded to standard therapies. When at least two therapies have been tried, and a patient still hasn’t responded, that patient is said to have treatment-resistant depression, according to clinic director Charles R. Conway, MD.
Inclement weather information
Should weather conditions create potentially hazardous travel conditions, Washington University will evaluate the situation and take into consideration the safety of the faculty, staff and students as well as the services that must be provided despite the inclement weather.
Brain scans show effects of Parkinson’s drug
Neuroscientists using a new brain imaging technique could see an investigational drug for Parkinson’s disease get into a patient’s brain and affect blood flow in several key structures, an indicator the drug may be effective. In the future, similar brain scans could speed the development of new drugs and help clinicians learn whether established drugs are working.
View More Stories